Emphysema Treatment

Emphysema is one of the common lung diseases that form part of the chronic obstructive pulmonary disease (COPD). The management of this condition includes lifestyle changes, exercises, pulmonary rehabilitation as well as pharmacotherapy and surgery.

Cessation of smoking

Smoking (as well as passive exposure to cigarette smoke) remains one of the best known and most closely associated causes of emphysema. The first step to treating emphysema is to quit smoking.

Nicotine replacement therapy and other smoking cessation aids and medications may be used to stop smoking.

Studies like the Lung Health Study have shown that stopping smoking at any time even after diagnosis of emphysema may help reduce the risk of progression of lung damage.

Lifestyle changes

Healthy lifestyle habits include a healthy balanced diet as well as regular physical exercise. Patients are encouraged to avoid dust, air pollutants, exposure to second hand smoke etc.

Regular immunizations

Some regular immunizations are necessary for emphysema patients. These include immunization against influenza with annual influenza vaccination and immunizations against pneumococcal infections at least once and repeated in 5-10 years. This is particularly important for people over the age of 50.

Pulmonary rehabilitation program

A pulmonary rehabilitation program may be suggested in patients living in areas where community respiratory services are available.

Oxygen therapy is administered to maintain the normal blood levels of oxygen. The goal of oxygen therapy is to maintain PaO2 ≥ 60 mmHg or SpO2 ≥ 90% at rest. Oxygen therapy may be a useful addition to pulmonary rehabilitation

Medication in management of emphysema

The management of emphysema is similar to management of COPD. The main treatment is with the use of bronchodilators. These help in opening up of the narrowed airways and thus provide relief from breathlessness by increasing fresh air flow into the lungs.

  • Bronchodilators – these may be a short-acting inhaled beta2 agonist like Salbutamol or antimuscarinic inhaled agent like ipratropium. In mild cases they are to be used as needed. Ipratropium is the first step in therapy. For moderate to severe cases regular use of ipratropium or a long-acting antimuscarinic agent tiotropium or long-acting beta2 agonist (LABA) like Salmeterol, Formoterol etc. are advised. Concurrent use of tiotropium and ipratropium is not recommended.
  • Mucolytic medicine is given as tablets or syrup and makes sputum thinner and runnier, making it easier to cough up.
  • Corticosteroids – these reduce the inflammation within the lungs. For patients with moderate to severe COPD with a history of exacerbations that occur more than one per year on average, for two consecutive years, inhaled corticosteroids (e.g. budesonide, fluticasone etc.) may be advised. These can be used regularly in combination with tiotropium and LABA therapy to reduce exacerbations. For flare ups and exacerbations, oral or injectable steroids may be used
  • Theophylline is another group of bronchodilator that is taken as pills. These are advised in patients with persistent symptoms despite optimal inhaled therapy.
  • Antibiotics – these are prescribed for the lung infections that are common in patients with emphysema. The common microbes that affect these patients include H. influenzae, S. pneumonia, C. pneumoniae, and M. pneumoniae. These agents are effectively treated with macrolides, fluoroquinolones, second generation cephalosporins, cotrimoxazole, or doxycycline for five to seven days.

Further Reading

Last Updated: Jul 8, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 08). Emphysema Treatment. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Emphysema-Treatment.aspx.

  • MLA

    Mandal, Ananya. "Emphysema Treatment". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Emphysema-Treatment.aspx>.

  • Chicago

    Mandal, Ananya. "Emphysema Treatment". News-Medical. https://www.news-medical.net/health/Emphysema-Treatment.aspx. (accessed October 31, 2024).

  • Harvard

    Mandal, Ananya. 2023. Emphysema Treatment. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Emphysema-Treatment.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined marijuana and cigarette smoking may increase lung damage